AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 185 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,225 | +0.9% | 450 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $35,910 | +0.3% | 450 | 0.0% | 0.01% | -10.0% |
| Q4 2023 | $35,816 | +13.9% | 450 | 0.0% | 0.01% | -9.1% |
| Q3 2023 | $31,450 | -2.7% | 450 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $32,337 | +16.5% | 450 | 0.0% | 0.01% | +10.0% |
| Q1 2023 | $27,756 | +38.2% | 450 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $20,079 | +0.4% | 450 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $20,000 | +11.1% | 450 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $18,000 | -5.3% | 450 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $19,000 | +11.8% | 450 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $17,000 | -64.6% | 450 | -69.0% | 0.01% | -66.7% |
| Q3 2021 | $48,000 | – | 1,450 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |